Clinical Trials Browser

Rectal Neoplasms

Advanced Primary Liver Cancer

Locally Advanced Pancreatic Carcinoma(LAPC)

Rectal Neoplasms

Stomach Neoplasms

Advanced Rectal Cancer

Pancreatic Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Pancreatic Adenocarcinoma

Colorectal Neoplasms

Adenocarcinoma Of Esophagus, Neoplasm Metastasis

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Breast Neoplasms

Liver Neoplasms, Pancreatic Neoplasms

Rectal Neoplasms

Peritoneal Neoplasms

Stomach Neoplasms

Carcinoma, Basal Cell, Ovarian Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Clinical Trials

NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer

A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer

CORRECT

Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer

Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

Study of Vitamin D in Untreated Metastatic Colorectal Cancer

Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)

Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum

S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer

Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)

Neo-Adjuvant FOLFOX for Rectal Carcinoma

Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer

Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets

5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer

A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis

FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer

A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen